JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slater, I. H.
Right arrow Articles by Dresel, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slater, I. H.
Right arrow Articles by Dresel, P. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 111, Issue 2, 182-196, 1954
Copyright © 1954 by American Society for Pharmacology and Experimental Therapeutics


DIETHYLBUTANEDIOL, A CONVULSANT HOMOLOGUE OF THE DEPRESSANT, DIETHYLPROPANEDIOL

I. H. Slater 1, D. E. Leary 1, and P. E. Dresel 2

1 Department of Surgery, Division of Orthopedics and Department of Radiation Biology, Division of Pharmacology, University of Rochester School of Medicine and Dentistry, Rochester, New York
2 Department of Pharmacology, Emory University School of Medicine, Emory University, Georgia

1. 2,2-Diethyl-1,3-propanediol is a potent central nervous system depressant and anticonvulsant remarkable for its potency in protecting animals against the lethal and convulsant effects of pentylenetetrazole. 2,2-Diethyl-1,4- butanediol, a compound with but one additional methylene group, is a potent convulsant in mice, rats, cats and rabbits. Large doses of diethyl-butanediol, exceeding the median lethal dose by about fifty times kill mice by a depressant action.

2. Pentylenetetrazole and DEB were found to be incompletely additive when given as mixtures. Diethyl-propanediol and other anticonvulsants such as phenobarbital and trimethadione antagonized the convulsant and lethal effects of DEB in mice. This suggests that the "oppositeness of action" is not specific but is merely another example of pharmacologic antagonism.

3. Examination of the action of DEB on cats has shown the compound is capable of giving rise to stimulation and convulsive patterns at all levels of the central nervous system. The site of greatest susceptibility appears to lie in the brain stem.

4. DEB induced convulsions were arrested during stimulation of the bulbar reticular inhibitory region.

5. Studies of oxygen uptake by rat brain homogenate failed to establish any difference between the two drugs. Both compounds caused an inhibition of QO2 at a concentration of 8-10 mM/1.

Submitted on February 13, 1954




This article has been cited by other articles:


Home page
ScienceHome page
B. H. MARKS
Effect of Barbiturates on Acetylation
Science, February 24, 1956; 123(3191): 332 - 333.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1954 by the American Society for Pharmacology and Experimental Therapeutics.